Safety procedures for exercise testing in the scenario of COVID-19: a position statement of the Societ\ue0 Italiana Scienze Motorie e Sportive by Venturelli, Massimo et al.
Vol.:(0123456789) 
Sport Sciences for Health 
https://doi.org/10.1007/s11332-020-00694-8
GUIDELINES
Safety procedures for exercise testing in the scenario of COVID‑19: 
a position statement of the Società Italiana Scienze Motorie e Sportive
Massimo Venturelli1,2  · Emiliano Cè3,4 · Mara Paneroni5 · Marco Guazzi6,7 · Giuseppe Lippi8 · Antonio Paoli9 · 
Carlo Baldari10 · Federico Schena1,11 · Fabio Esposito3,4
Received: 31 July 2020 / Accepted: 21 August 2020 
© The Author(s) 2020
Abstract
Recent data on coronavirus disease 2019 (COVID-19) pandemic showed that the virus is mostly conveyed by respiratory 
droplets that are produced at high intensity especially when an infected subject coughs or sneezes. Therefore, elevated volume 
ventilations, usually reached during physical efforts and exercise, are a potential source of contamination. On the other hand, 
the lockdown period which has lasted for nearly 2 months and is actually involving several countries worldwide, obliged a 
large part of human population to sedentary behaviors, drastically reducing their physical activity level, and reducing their 
cardiopulmonary fitness. Therefore, cardiopulmonary exercise testing could be beneficial, so that a safe and well-weighted 
return to pre-lockdown active lifestyle can be efficiently planned. However, specific guidelines on exercise testing safety 
procedures in the era of COVID-19 are unavailable so far. This article is aimed to provide an overview of safety procedures 
for exercise testing during and after COVID-19 worldwide pandemic.
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Introduction
Exercise testing is a well-established procedure, that has 
been extensively used for several decades in clinical and 
sub-clinical set-up. It is beyond the scope of this manuscript 
to provide detailed descriptions of these procedures, because 
exhaustive reports are available in previous publications of 
the American Heart Association (AHA), European Heart 
Association (EHA), and the American College of Sport 
Medicine (ACSM), to which interested readers can be 
referred [1–3]. This article is instead aimed to provide an 
overview of safety procedures for exercise testing during 
and after coronavirus disease 2019 (COVID-19) worldwide 
pandemic.
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Introduction to the COVID‑19
Data from the World Health Organization (WHO) have 
revealed that COVID-19 is a worldwide pandemic, which 
has now infected many million patients around the world 
and has already caused a dramatic number of deaths. Despite 
the number of new cases has considerably stabilized or has 
even declined in some countries, a large number of COVID-
19 patients will now experience long-term sequels impacting 
both the pulmonary and cardiovascular systems [4]. SARS-
CoV-2 interplays with the pulmonary cardiovascular systems 
on multiple levels, not only increasing morbidity in patients 
with lungs and cardiovascular diseases, but also potentially 
exacerbating many underlying dysfunctions [5]. The causal 
agent of COVID-19, SARS-CoV-2, enter the host cells through 
its natural receptor angiotensin-converting enzyme 2 (ACE2). 
This protein is expressed at the surface of cells of many tissues 
and organs, such as nose, tongue, lung, heart, gastrointestinal 
system, adipose tissue, vascular endothelium, liver, kidney and 
testis, thus accounting the multiple organ dysfunction (MOF) 
that can develop in patients with severe/critical SARS-CoV-2 
infection [6]. The presence of mild symptoms is disproportion-
ate to the severity of illness [7]. The most common symptoms 
encompass fever (98%), cough (77%), dyspnea (63.5%) and 
muscle and joint soreness [8]. The rationale of symptoms dis-
tribution across organs is partially explained by the distribution 
and expression level of ACE-2, which is particularly enriched 
in above-mentioned organs and tissues [5, 6].
The role of exercise testing in asymptomatic 
individuals
Asymptomatic individuals often present an apparently health 
status, however, they could still be positive to SARS-CoV-2 
and potentially being contagious, although this last point is still 
a matter of debate toward the medical community. The use of 
safety procedures, though, becomes imperative in particular 
when testing an asymptomatic individual [10].
The lockdown period which has lasted for nearly 2 months 
and is actually involving several countries worldwide, obliged 
a large part of human population to sedentary behaviors, dras-
tically reducing their physical activity level, and thus possibly 
reducing their cardiopulmonary health [11, 12]. Therefore, car-
diopulmonary exercise testing could be beneficial, so that a 
safe and well-weighted return to pre-lockdown active lifestyle 
can be efficiently planned.
Indications and safety
Recent data on COVID-19 pandemic showed that the virus 
is mostly conveyed by respiratory droplets that are produced 
at high intensity especially when an infected subject coughs 
or sneezes. These droplets can be inhaled into the lungs of 
individuals in the close proximity (< 1 m), or can land on 
surfaces, where they can then be touched and transported by 
hand to the body [13]. Current WHO and National Centers 
for Disease Control and Prevention recommendations for 
use of personal protective equipment (PPE) are in agreement 
that standard, contact precautions with face mask, eye pro-
tection, gown, and gloves will be necessary. When perform-
ing procedures that encompass the risk of generating aero-
sol, such as exercise testing, additional PPE may be required, 
including controlled or powered air purifying respirators and 
specific face mask for the personnel in the close proximity 
of patients performing the test. These procedures should be 
followed both while testing post-COVID-19 patients most 
important when we test asymptomatic individuals. However, 
while with the former the main goal is to prevent the onset 
of a relapse (their possible contagious level is still a point 
of discussion), with asymptomatic subject (with unknown 
infection status) the risk is to underestimate their possible 
infectious.
Measures to prevent infection 
by SARS‑CoV‑2
The subjects at higher risk of SARS-CoV-2 infectiveness 
are those who in close contact with COVID-19 patients, 
and thereby healthcare workers engaged assistance to the 
patients or laboratory staff engaged in handling biological 
samples of COVID-19 patients without recommended PPE 
or using unsuitable PPE (Table 1). It is hence essential that 
the personnel involved is properly trained and educated on 
the risks of work-associated risk exposure, on the available 
prevention and protection measures, as well as on the clinical 
features of COVID-19. The most effective prevention meas-
ures that shall be applied in the healthcare sector, including 
personnel dedicated to the exercise testing procedure, are:
• To frequently wash hand using soap or alcohol-based 
solution or hand sanitizing gel.
• Avoid touching eyes, nose, and mouth with the hands;
• Coughing or sneezing inside the elbow, with the arm 
bent or a handkerchief, preferably disposable, which 
must then be immediately eliminated;
• Always wear a surgical mask and perform hand hygiene 
after removing the mask;
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• Avoid close contact by keeping the distance of at least 
1 m (preferably 2 m, whenever feasible) from other peo-
ple, especially those with respiratory symptoms.
Additional precautions seem necessary, including the cor-
rect use of PPE along with appropriate education on their 
wearing, usage, undressing and elimination. This is espe-
cially important considering that although the leading means 
of SARS-CoV-2 transmission are through droplets and direct 
contact, specific maneuvers and other activities which may 
generate aerosols are also listed as potential risk procedures. 
Hand hygiene and appropriate use of PPE is hence always 
essential to prevent contact transmission.
Nevertheless, PPE are effective for protecting operators 
only in combination with a larger set of measures introduced 
among administrative procedural and technical activities for 
promotion of health-care setting.
In particular, in the current epidemiological scenario and 
with an ongoing risk of global shortage of PPE, the follow-
ing WHO recommendations about the need to optimize their 
use shall be especially adopted:
• Ensure appropriate use of PPE;
• Ensure availability of a sufficient quantity and quality of 
PPE for protecting operators and people according to the 
specific risk of infection;
• Coordinate the management of PPE supply chain.
All the personnel involved in exercise testing procedure 
shall also be:
1. Appropriately trained and updated on occupational 
exposure risks and measures of prevention and protec-
tion;
2. Aware of the leading clinical features of COVID-19, so 
enabling timely identification and isolation of suspected 
cases;
3. Invited to participate to specific training and courses;
4. Aware of the importance of adopting standard precau-
tions in assisting patients, with specific focus on hand 
hygiene before and after contacts with patients.
Triaging subjects and visits
The use of telemedicine remote diagnosis and treatment of 
patients by means of telecommunications technology is one 
of the leading measures to help preventing further spread 
of COVID-19 (Fig. 1). This technology, already used by 
various health care systems and hospitals [14], is ideal in 
a pandemic scenario emergencies since it limit exposure to 
asymptomatic (but possibly contagious) individuals. Other 
essential principles are minimization of direct patient–per-
sonnel interactions and number of health-care specialist 
required for the management of each patient to the mini-
mum required.
Personal protective equipment
In the current COVID-19 emergency situation, the PPE 
selection shall be based on the risk of SARS-CoV-2 trans-
mission, which depends on:
• Means of transmission (especially through droplets and/
or direct contact);
• Type of patient: the most contagious patients are those 
with cough and/or sneeze; if these patients wear a face 
Table 1  PPE for exercise testing procedures
CPET cardiopulmonary exercise test
a This may be single or reusable face/eye protection/full face visor or goggles
Setting Target personnel or patients Activity PPE equipment
Triage Health professional/technician/physiologist Preliminary screening (does 




CPET laboratory Health professional/technician/physiologist CPET Single use disposable Gloves
Disposable fluid-resistant coverall/gown




Subject/patient CPET Hands/arm washing before/after
Surgical mask before/after
Transit area Health professional/lab technician/physiologist Surgical mask
Subject/patient Surgical mask
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mask or cover nose and mouth with a tissue, virus spread 
can be considerably lowered;
• Type of care contact—the risk increases when:
• The contact is close (< 1  m) and prolonged 
(> 15 min).
• The contact is repeated or continuous, so that it will 
increase the overall exposure time in the hospital and 
in other health care environments (such as for opera-
tors involved in repeated and/or continued medical 
assistance/evaluation of suspected and confirmed 
COVID-19 cases)
• Performing maneuvers and procedures at high risk 
of producing aerosols, especially managing patient 
secretions.
In a context of emergencies and lack of PPE, facial filters 
such as FFP2 or FFP3 must be prioritized for health care 
professionals engaged in areas where procedures are carried 
out to risk of aerosol generation such as gym, recreational 
association, sport association or during exercise testing.
Table 1 describes the main PPEs that shall be used during 
exercise testing in post-COVID-19 scenario.
Cleaning and safety procedures 
for the instruments
During testing, parts in direct contact with patient skin or 
mucosa, masks used for gas exchange analyses, even small 
condensation droplets or aerosols are possible contaminants. 
Therefore, all potentially contaminated parts must be used 
according to the time requested to the cleaning, as indicated 
by the manufacturer [15].
Since the safety of patients and staff is extremely impor-
tant, the European Respiratory Society (ERS) recommend 
E-Visit/telehealth for subject 
management and triage 
Does the subject 
refer fever, cough, 
body aches, and 
sore throat?
Is a subject 
currently positive 
to the COVID-19?





Is the subject 










Is a subject 
currently positive 








exercise test after 
negative throat swab 
samples
Pre exercise test triage 
Is the body temperature 













exercise test after 
negative throat swab 















Does the subject 
refer dyspnea at 
rest or during 
daily life 
activities?
Does the subject 
refer fatigue at rest 











exercise test after 
pulmonologist 
evaluation 
Fig. 1  Exercise testing triage. E-visit = on-line consultation;  SpO2 = blood oxygen saturation
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specific safety precautions while carrying out Lung function 
testing during COVID-19 pandemic [16]:
• Lung function testing should be performed always with 
a high specification disposable in-line bacterial and viral 
filter in place (with minimum proven efficiency for high 
expiratory flow of 600–700 L/min). The use of dispos-
able combined mouthpieces/sensors is not recommended 
at this time. The only exception is when a filter is added.
• Maximize the use of single use consumables and dis-
pose of the items with care e.g. nose clips, rubber mouth-
pieces, etc.
• Where reusable items are utilized, they should be man-
aged carefully and should be thoroughly cleaned as rec-
ommended by local infection control policy.
• Use filters to minimize escape of aerosol from the 
exhalation ports when using nebulizers.
• During exercise testing, the use of filters connected 
to the inhalation/exhalation port of the facemask or 
mouthpiece can reduce the aerosol transmission. 
This could result in an increase the resistance to air-
flow as the ventilatory demand of exercise increases 
(humidification of the filter and increase of the resist-
ance at increased ventilatory flow), therefore, render-
ing the results of exercise less reliable, especially in 
dyspneic patients. However, more work needs to be 
done in this area before a consensus on their use can 
be agreed. Thus, the use of filters during exercise 
testing cannot be recommended and full PPE must 
be worn when conducting these tests.
Re-usable parts, when properly maintained and reused 
according to these instructions, should be verified to func-
tion within basic specifications for a minimum of 50 cycles. 
Proper functioning of applicable parts after reprocessing 
shall be checked with both flowmeter and gas calibration, 
verifying that the values of all calibration factors are within 
acceptable range (Table 2) [17].
In preparing the devices for cardiopulmonary testing, or 
at the end of the test, the following general indications shall 
be considered:
• Assign trained and qualified staff for handing and reuse 
of components.
• Do not immerse the device or pour cleaning liquids over 
and into the device.
• To minimize the infection risk and maintain optimal per-
formance, verify that:
• Device and re-usable parts are cleaned and disin-
fected prior their first usage
• Single-use items are disposed after each test
• Parts showing defects on material surfaces (cracks, brit-
tleness) are disposed and standard personal protective 
(PPE) measures (hand hygiene, gloves, gown, mask, face 
shields) are always used when necessary
• Re-usable parts are disinfected immediately after use
Moreover, solutions for disinfection shall be:
• Applied thoroughly to all surfaces of the instruments 
needing disinfection
• Used according to the instructions and the length of con-
tact provided by the manufacturer
• Always stored and prepared in clearly marked containers, 
thus preventing accidental use/misuse
Reprocessing
Rinsing is a very important activity in the reprocessing pro-
cedure, aimed to remove organic material, lubricants, or 
even cleaning agents that can deactivate the chemical liq-
uid disinfectants and thus inhibit the anti-microbial effect. 
Sterile water is recommended for rinsing, when available, 
though the use of potable tap water can also be accepted 
[18, 19].
Pretreatment
The pretreatment should be completed as soon as possible 
after use.
When choosing a suitable detergent and disinfectant, it 
shall be considered that:
Table 2  Antimicrobial agents effective against various coronaviruses
Modified from “European Centre for Disease Prevention and Control. 
Interim guidance for environmental cleaning in non-healthcare facili-
ties exposed to SARS-CoV-2. Stockholm: ECDC; Lehuman corona-
virus
229E HCoV-229E, MHV-2 and MHV-N mouse hepatitis virus, CCV 
canine coronavirus, TGEV transmissible gastroenteritis virus, SARS-
CoV2 respiratory syndrome coronavirus acute severe
Antimicrobial agent Concentration (%) Coronaviruses tested
Ethyl alcohol 70 HCoV-229E, MHV-






Povidone-iodine 10 (1% iodine) HCoV-229E
Glutaraldehyde 2 HCoV-229E
Isopropanol 50 MHV-2, MHV-N, CCV
Benzalkonium chloride 0.05 MHV-2, MHV-N, CCV
Sodium chlorite 0.23 MHV-2, MHV-N, CCV
Formaldehyde 0.7 MHV-2, MHV-N, CCV
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• Manufacturer’s safety precautions must be strictly 
observed, and adapted for cleaning and disinfection of 
metal and plastic instruments;
• The agent used has proven antimicrobial efficacy (e.g., 
CE marked or legally marketed in the US);
• The chemicals are compatible with re-usable parts;
• The manufacturer’s specifications on concentration and 
reaction time must be always respected.
Maintenance
Disassembled components need to be reassembled after 
reprocessing. After cleaning and disinfection, the o-rings 
shall be lubricated with medical grade biocompatible 
Vaseline.
Conclusions
This article is aimed to provide an overview of safety proce-
dures for exercise testing during and after COVID-19 world-
wide pandemic. The safety recommendations presented in 
this manuscript applied into exercise physiology laboratory, 
gym, sport association, etc. and integrated with updated 
local guidelines according to the local laws and WHO safety 
recommendations for the COVID-19 pandemic.
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